Small-Molecule Antiviral β- <scp>d</scp> - <i>N</i> <sup>4</sup> -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to ResistanceMaria L. Agostini, Mark R. Denison, Alexander A. Kolykhalov et al.|Journal of Virology|2019Cited by 355
The coronavirus proofreading exoribonuclease mediates extensive viral recombinationJennifer Gribble, Mark R. Denison, Laura J. Stevens et al.|PLoS Pathogens|2021Cited by 291
Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanismsLaura J. Stevens, Mark R. Denison, Andrea J. Pruijssers et al.|Science Translational Medicine|2022Cited by 258
The coronavirus proofreading exoribonuclease mediates extensive viral recombinationJennifer Gribble, Mark R. Denison, Andrea J. Pruijssers et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 33
A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistanceSamantha L. Grimes, Mark R. Denison, Young Joo Choi et al.|mBio|2023Cited by 21